Towards comprehensive characterization of HER2 overexpression

Molecular Systems Biology

Volumn 2, Issue , 2006, Pages

  Berezov, Alan ^a   Greene, Mark I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; G PROTEIN COUPLED RECEPTOR; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; NEU DIFFERENTIATION FACTOR; SURVIVIN; TRASTUZUMAB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; PHOSPHOTYROSINE;

BREAST CANCER; BREAST EPITHELIUM; CANCER INHIBITION; CANCER THERAPY; CELL MIGRATION; CELL PROLIFERATION; DATA ANALYSIS; DIMERIZATION; GENE OVEREXPRESSION; HUMAN; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MONOTHERAPY; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SELF ORGANIZING MAP CLUSTERING; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR GROWTH; BIOSYNTHESIS; BREAST; CELL DIVISION; CELL LINE; CELL MOTION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; NOTE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; PROTO ONCOGENE;

BREAST; CELL DIVISION; CELL LINE; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENES, ERBB-1; GENES, ERBB-2; HUMANS; MASS SPECTROMETRY; NEUREGULIN-1; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 33750692700     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb4100097     Document Type: Short Survey

References (8)

1. Ciardiello F, Troiani T, Bianco R, Orditura M, Morgillo F, Martinelli E, Morelli MP, Cascone T, Tortora G (2006) Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy. Ann Oncol 17: vii109-vii114
2. Dubska L, Andera L, Sheard MA (2005) HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis. FEBS Lett 579: 4149-4158
3. Jones RB, Gordus A, Krall JA, MacBeath G (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439: 168-174
4. Ohtsu H, Dempsey PJ, Eguchi S (2006) ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291: C1-C10
5. Schulze WX, Deng L, Mann M (2005) Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol 1: 42-54
6. Uetz P, Stagljar I (2006) The interactome of human EGF/ErbB receptors. Mol Syst Biol, Pubmed Identification Number: 2006.0006; doi:10.1038/msb4100048
7. Wang Q, Greene MI (2005) EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Exp Mol Pathol 79: 100-107
8. Wolf-Yadlin A, Kumar N, Zhang Y, Hautaniemi S, Zaman M, Hyung-Do K, Grantcharova V, Lauffenburger DA, White FM (2006) HER2-overexpression effects on cell signaling networks governing proliferation and migration. Mol Syst Biol, Pubmed Identification Number: 54; doi:10.1038/msb4100094